Anthrax - 40 Studies Found
| Completed |
: Safety, Tolerability, and PK of Single IM Doses of ETI-204 in Adult Volunteers : Inhalational Anthrax : 2013-08-02 :
|
| Completed |
: Safety, Tolerability and PK of Repeat Administration of IV ETI-204 : Inhalational Anthrax : 2013-08-02 :
|
| Completed |
: A Study to Assess the Safety, Tolerability and PK of a Single IV Dose of ETI-204 in Adult Volunteers : Inhalational Anthrax : 2013-08-02 :
|
| Completed |
: CDC Anthrax Vaccine Clinical Trial : Healthy : 2005-07-06 : Biological: BioThrax or Anthrax Vaccine Adsorbed |
| Completed |
: An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection : Therapeutic Treatment of Inhalation Anthrax : 2013-12-16 : Biological: Raxibacumab Raxibacumab will be supplied in 50 milliliter (mL) sterile, single-use vials con |
| Active, not recruiting |
: Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed : Infections, Bacterial : 2015-01-12 :
|
| Completed |
: VHA Clinicians and Bioterror Events: Interactive Web-based Learning :
: 2005-07-20 : Behavioral: BioCASES and BioTESTS |
| Completed |
: Special Drug Use Investigation of Ciproxan Injection in Pediatrics : Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax : 2015-09-18 : Drug: Cipro (Ciprofloxacin, BAYQ3939) Treatment parameters following the physician's decision based on t |
| Not yet recruiting |
: An Open Label, Phase IV Study Evaluating the Clinical Benefit, Safety and Pharmacokinetics of Raxibacumab in Subjects Exposed to Bacillus Anthracis : Infections, Bacterial : 2014-05-15 : Other: Collection of samples Whenever possible serum sampl |
| Completed |
: Anthrax AV7909 Boost Evaluation Study : Anthrax : 2025-08-02 : AV7909 Anthrax Vaccine is being developed by Emergent Product Development Gaithersburg Inc. (Emergent) for PEP of disease in persons 18 through 65 yea |